A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network-Reference-Cited by-同舟云学术

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network

Published:2005-08 Issue:8 Volume:100 Page:1090-1100
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:

Author:

Ling Walter,Amass Leslie,Shoptaw Steve,Annon Jeffrey J.,Hillhouse Maureen,Babcock Dean,Brigham Greg,Harrer Judy,Reid Malcolm,Muir Joan,Buchan Betty,Orr Debbie,Woody George,Krejci Jonathan,Ziedonis Douglas,

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1360-0443.2005.01154.x/fullpdf

Reference27 articles.

1. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification;Amass;Journal of Addictive Diseases,1994

2. Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet;Amass;Drug and Alcohol Dependence,2000

3. Bringing buprenorphine--naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field Experience;Amass;American Journal on Addictions,2004

4. Gradual dose taper following chronic buprenorphine;Becker;American Journal on Addictions,2001

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient;International Journal of Drug Policy;2024-08

2. Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders;Drug and Alcohol Dependence;2024-08

3. Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2024-06

4. Pharmacological Treatment of Substance Use Disorders;Tasman’s Psychiatry;2024

5. Disorders due to Substance Use: Opioids and Opioid Addiction;Tasman’s Psychiatry;2024